Efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients, a randomized controlled trial - "Pharm-MD" : Impact of clinical pharmacists in diabetes care

Alexandra Halalau, Melda Sonmez, Ahsan Uddin, Patrick Karabon, Zachary Scherzer, Scott Keeney, Alexandra Halalau, Melda Sonmez, Ahsan Uddin, Patrick Karabon, Zachary Scherzer, Scott Keeney

Abstract

Background: Diabetes mellitus affects 13% of American adults. To address the complex care requirements necessary to avoid diabetes-related morbidity, the American Diabetes Association recommends utilization of multidisciplinary teams. Research shows pharmacists have a positive impact on multiple clinical diabetic outcomes.

Methods: Open-label randomized controlled trial with 1:1 assignment that took place in a single institution resident-run outpatient medicine clinic. Patients 18-75 years old with type 2 diabetes mellitus and most recent HbA1c ≥9% were randomized to standard of care (SOC) (continued with routine follow up with their primary provider) or to the SOC + pharmacist-managed diabetes clinic PMDC group (had an additional 6 visits with the pharmacist within 6 months from enrollment). Patients were followed for 12 months after enrollment. Data collected included HbA1c, lipid panel, statin use, blood pressure control, immunization status, and evidence of diabetic complications (retinopathy, nephropathy, neuropathy). Intention-to-treat and per-protocol analysis were performed.

Results: Forty-four patients were enrolled in the SOC + PMDC group and 42 patients in the SOC group. Average decrease in HbA1c for the intervention compared to the control group at 6 months was - 2.85% vs. -1.32%, (p = 0.0051). Additionally, the odds of achieving a goal HbA1c of ≤8% at 6 months was 3.15 (95% CI = 1.18, 8.42, p = 0.0222) in the intervention versus control group. There was no statistically significant difference in the remaining secondary outcomes measured.

Conclusions: Addition of pharmacist managed care for patients with type 2 diabetes mellitus is associated with significant improvements in HbA1c compared with standard of care alone. Missing data during follow up limited the power of secondary outcomes analyses.

Trial registration: ClinicalTrials.gov , ID: NCT03377127 ; first posted on 19/12/2017.

Keywords: Diabetes; Hemoglobin A1c; Managed care; Pharmacy.

Conflict of interest statement

The authors have no financial or non-financial competing interests to declare.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Patient enrollment flow diagram

References

    1. National Diabetes Statistics Report . Centers for Disease Control and Prevention, U.S. Atlanta: Dept of health and human services; 2017.
    1. Boyle JP, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24(11):1936–1940. doi: 10.2337/diacare.24.11.1936.
    1. Strategies for Improving Care Diabetes Care. 2016;39(Suppl 1):S6–12.
    1. Pousinho S, et al. Pharmacist interventions in the Management of Type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22(5):493–515.
    1. Allah, B et al. (2018) Efficacy of pharmacist based diabetes educational interventions on clinical outcomes of adults with type 2 diabetes mellitus: a network Meta-analysis. Frontiers in pharmacology 9. Online publication date: 10-Apr-2018.
    1. Aneese, N.J., et al., Impact of a pharmacist-managed diabetes clinic on quality measures. Am J Manag Care, 2018;24(4 Spec No): Sp116-sp119.
    1. Halalau A, et al. Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients - study protocol for a randomized controlled trial. Trials. 2018;19(1):458. doi: 10.1186/s13063-018-2836-8.
    1. Stratton IM, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj. 2000;321(7258):405–412. doi: 10.1136/bmj.321.7258.405.
    1. Ip EJ, et al. Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health Syst Pharm. 2013;70(10):877–886. doi: 10.2146/ajhp120238.
    1. Coast-Senior EA, et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998;32(6):636–641. doi: 10.1345/aph.17095.
    1. Leal S, et al. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27(12):2983–2984. doi: 10.2337/diacare.27.12.2983.
    1. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26(2):248–253. doi: 10.1592/phco.26.2.248.
    1. Pousinho S, Morgado M, Plácido AI, Roque F, Falcão A, Alves G. Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharm Pract (Granada) 2020;18(3):2000. doi: 10.18549/PharmPract.2020.3.2000.
    1. Choe HM, et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11(4):253–260.
    1. Healthcare Effectiveness Data and Information Set:
    1. Abdulrhim S, et al. Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data. Int J Clin Pharm. 2021. 10.1007/s11096-021-01327-x Epub ahead of print. PMID: .
    1. Dixon D, et al. Effect of a physician/pharmacist collaborative care model on time in target range for systolic blood pressure: post hoc analysis of the CAPTION trial. Hypertension. 2021;78(4):966–972. doi: 10.1161/HYPERTENSIONAHA.121.17873.
    1. Cowart K, et al. Measurement of pharmacist-physician collaborative care on therapeutic inertia in patients with type 2 diabetes. Ann Pharmacother. 2021;9:10600280211023492. doi: 10.1177/10600280211023492.
    1. American Diabetes Association (ADA)

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa